March 25, 2025 Breaking Down Research: Investigation of Urinary miRNAs for Early Detection of Kidney Damage in selected lab animals Drug-induced kidney injury is commonly identified during drug development and serves as a dose-limiting factor...
March 24, 2025 Lysosomal Storage Disease Data Sharing Workshop, Webinar Series Session #2: Case Studies #1 – Proactive Data Sharing This webinar from Critical Path Institute's Critical Path to Lysosomal Diseases Consortium presents...
March 21, 2025 The Critical Path Institute Podcast: Connecting the Dots with COA VP Dr. Cheryl Coon If you have attended one of C-Path’s stakeholder meetings, read one of our impact stories or engaged through our social...
March 21, 2025 Wrangling Real-World Data: Optimizing Clinical Research Through Factor Selection with LASSO Regression Data-driven approaches to clinical research are necessary for understanding and effectively treating infectious...
April 17, 2025 RDCA-DAP Webinar: ACE Inhibitors as a Cardioprotective Treatment in Dystrophinopathies ACE inhibitors were the first pharmacological class shown to benefit heart failure treatment...
March 10, 2025 C-Path’s Critical Path for Parkinson’s Consortium Welcomes CND Life Sciences C-Path is excited to welcome CND Life Sciences as the newest member of it Critical Path for Parkinson’s (CPP)...
February 26, 2025 Transforming Data into Breakthroughs: 5 Years of RDCA-DAP Journey and Impact In honor of Rare Disease Month, Alexandre Bétourné took some time to sit down and discuss the impact RDCA-DAP has made...
February 24, 2025 Lysosomal Storage Disease Data Sharing Workshop, Webinar Series – Session #1: Setting the Scene C-Path's CPLD team presents, "Lysosomal Storage Disease Data Sharing Workshop, Webinar Series - Session #1...
February 20, 2025 Living with Young Onset Parkinson’s Disease: PD Community Advocate Sarah Zenner-Dolan’s Joins C-Path’s 20th Anniversary Celebration Critical Path for Parkinson's Consortium (CPP) Advisor and FDA Advisory Committee Member Sarah Zenner-Dolan...
February 19, 2025 Advancing Neonatal Drug Development Through Collaboration At C-Path’s INC, we believe that meaningful progress in neonatal drug development...
